BioScrip Inc Stock Nasdaq
Equities
US09069N1081
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 4.74B | Sales 2025 * | 5.16B | Capitalization | 5.15B |
---|---|---|---|---|---|
Net income 2024 * | 204M | Net income 2025 * | 233M | EV / Sales 2024 * | 1.22 x |
Net Debt 2024 * | 659M | Net Debt 2025 * | 350M | EV / Sales 2025 * | 1.06 x |
P/E ratio 2024 * |
25.5
x | P/E ratio 2025 * |
22.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.9% |
Latest transcript on BioScrip Inc
Managers | Title | Age | Since |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 19-08-05 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 14-12-31 |
Caroline Budde
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 19-08-06 |
David Golding
BRD | Director/Board Member | 62 | 15-04-30 |
John Arlotta
BRD | Director/Board Member | 74 | 19-08-06 |
1st Jan change | Capi. | |
---|---|---|
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |